Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (6345)	7/15/1998 1:18:00 PM
From: musicguy	Read Replies (1) \| Respond to of 25711

BLUE... was someone here mentioning it recently? I just bought 1000 just for the hell of it.. volume way up, and price up 13%... Gross sales for the 1998 and 1997 first quarters were $1,014,837 and $265,814, respectively, an increase of $749,023 or 281.8%, in 1998 compared to 1997. MG

To: Joe Copia who wrote (6345)	7/15/1998 10:20:00 PM
From: hoffy	Read Replies (1) \| Respond to of 25711

IATV Joe: Have you ever looked at this company before. I recently have and like what I see so far. Here's the website to research it for yourself. actv.com

To: Joe Copia who wrote (6345)	7/16/1998 12:21:00 AM
From: David Sirk	Read Replies (1) \| Respond to of 25711

PRWT is getting ready for a move like BAAT. it's get rich time!

To: Joe Copia who wrote (6345)	7/16/1998 8:59:00 AM
From: Mykldee	Respond to of 25711

Thought "Approach life like a voyage on a schooner- enjoy the view, explore the vessel, make friends with the Captian, fish a little, and then get off when you get home." M. Lacedo

To: Joe Copia who wrote (6345)	7/16/1998 10:06:00 AM
From: LANCE B	Respond to of 25711

amcx---- news out if you have not seen my post before,this is my sons college tuition stock here........you can buy a bond or set up a college fund or you can buy americlean........your choice take the time to do a little dd on this company recycles not dump of waste and supplies division only competition is local mom and pop stores..........

To: Joe Copia who wrote (6345)	7/16/1998 10:12:00 AM
From: P.E. Allen	Respond to of 25711

TLK watch this one, might be expensive for this thread. but check it out. Stock is on the rebound a million shares already today. No DD, give, Wall Street loves this stock.

To: Joe Copia who wrote (6345)	7/16/1998 10:23:00 AM
From: Jason Flora	Read Replies (1) \| Respond to of 25711

HYALF - currently halted on news HYAL ANNOUNCES AGREEMENT IN PRINCIPLE TO LICENSE SOLARASE(TM) MISSISSAUGA, Ont., July 16 /CNW/ - Hyal Pharmaceutical Corporation (NASDAQ/NNM:HYALF; TSE:HPC) announced today that it has accepted an offer from Altana Inc., Melville, New York, for a license to the worldwide rights to Solarase, excluding those territories previously licensed to F.H. Faulding Inc. Solarase is Hyal's topical gel formulation to treat actinic keratosis, a precancerous skin condition caused by over-exposure to the sun. Solarase is approved to market in Canada, France, Germany, Italy, Sweden and the United Kingdom. A New Drug Application is expected to be filed with the U.S. FDA during the third quarter of 1998. The offer includes an up-front payment to Hyal and a royalty based on sales of Solarase. Altana Inc. is a wholly-owned subsidiary of Byk Gulden Lomberg Chemische Fabrik GmbH, a German multinational pharmaceutical company. Byk Gulden is a subsidiary of Altana AG. The Altana Inc. Pharmaceutical Group is a fully integrated pharmaceutical company with a major focus on the manufacturing and marketing of dermatological products. Hyal and Altana have also agreed to enter into a joint development agreement with the objective of obtaining regulatory approval of Hyanalgese-D for uses other than treatment of pain due to osteoarthritis. Pursuant to the joint development agreement, Altana will fund one half of the development costs and will be granted a worldwide license to Hyanalgese-D, excluding those territories previously licensed. In exchange, Altana will pay a royalty to Hyal on all sales arising in connection with the joint development agreement. The license and joint development agreements are expected to close in the third quarter of 1998 and are subject to a number of conditions including the execution of definitive agreements and final approval of the Board of Directors of Hyal and Altana. Dr. Zenas B. Noon, President and CEO stated: ''Hyal is excited to collaborate with a world class pharmaceutical partner of Altana's stature. Hyal believes that the up-front payments offered by Altana in connection with the license to Solarase will strengthen Hyal's financial position and enable Hyal to fund the continued development of promising product candidates''. Hyal Pharmaceutical Corporation is a drug delivery company engaged in research and development and is seeking worldwide commercialization of pharmaceutical formulations utilizing its proprietary Hyaluronan Induced Targeting (HIT)(TM) Technology and Hyaluronan Improved Liposome Technology (HILT)(TM). This news release may contain forward-looking statements relating to the future performance of Hyal. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company's filings with the appropriate securities commissions.

To: Joe Copia who wrote (6345)	7/16/1998 12:13:00 PM
From: ROSARIO	Read Replies (1) \| Respond to of 25711

Joe, what are your predictions on ZULU?? The DOUBLE CLICK CEO will be on CNBC in about 10-15 minutes!! Thanks

To: Joe Copia who wrote (6345)	7/16/1998 1:03:00 PM
From: Johnny Ro	Read Replies (2) \| Respond to of 25711

Advanced Voice Recognition, Inc. OTC_BB: AVRI PH# 713-621-5678 Shares Outstanding: 12.9M-13.2M (New IR Firm KCSA says 12.9M/AVRI says 13.2M) Shares in the Float: 2.2M Current bidxask:1.50x1.687 (11:20 EST 7/16/98) Debt=0 (per Bill Kennedy @ AVRI) Company: The company has been is in the Medical transcription business. The company has developed and is now marketing a product that allows a physician to dictate medical notes into a digital Dictaphone and plug the recorder into a PC and have the notes downloaded into a word processor file for clean up and printing. The great thing about this is the voice recognition technology is customized to each physician (or scientist or whomever) personal verbiage. So if your podiatrist starts rattling on about your bad ankle with all those $25.00 medical words, the voice recognition picks that up and will print it out. Why you ask would someone want this technology, well physician, as well as other professionals, hire transcriptionists or secretaries to do this work and if we can save the transcibers time by having all the notes right in front of him/her on a computer screen in a word processor, then all they have to do is a little grammar work and wallah! The company sells this Service bills it out at $400/month with a 39 month contract to sign up. Right now the service is being used at the Baylor Medical system, NASA & Texas A&M University to name a few some of you may have heard of. (also shows the diversity of applications for the service) News: AVRI just hired on KCSA in NY for IR services. KCSA is big time Wall Street. Talked to Paul Holm & Joe Mansi both with KCSA (212) 896-1205 or-1201 yesterday and a big time investment bank is set up. NASDAQ listing should be by year end. Oh Yeah, KCSA also represents Lernhout & Hauspie, another giant in the audio/voice recognition world. KCSA should help get the recognition on the street that AVRI deserves when it cracks into the NASDAQ. Links: More DD: insidewallstreet.com Chart: (see a trend with the news? This is the 1 yr, look at a 5 day on this one- looks pretty good!!) chart3.bigcharts.com Per Karen @ IR with AVRI the down turn was attributable to Rule 144 expirations being sold and then a general reaction by other investors seeing the exodus causing a sell off. (Take it for what you will) I see it as a price bottom/ground floor opportunity, others may see something else. Company Web Site: voicecommander.com (pretty cool site too!) As usual this is for informational purposes only. There is no notice to buy or sell this or any other equity. And of course my favorite, "do your own DD" Johnny Ro